ARS Pharmaceuticals (SPRY) Return on Equity [ROE] (2021 - 2026)
ARS Pharmaceuticals (SPRY) posted Return on Equity [ROE] of -585.93% for Q2 2026, down 557.76 percentage points from -28.17% a year earlier and down 355.34 percentage points from the prior quarter.
Powered by 
Analysis
ARS Pharmaceuticals (SPRY) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, ARS Pharmaceuticals' Return on Equity [ROE] came in at -92.33%, down 95.61 percentage points from FY2024.
- Annual Return on Equity [ROE] shows a three-year change of -62.93 percentage points (FY2022 to FY2025).
- In prior years, ARS Pharmaceuticals' Return on Equity [ROE] was 3.28% in FY2024 (+24.87 pp), -21.59% in FY2023 (+7.81 pp) and -29.40% in FY2022.
- The Q2 2026 figure stands as the lowest quarterly Return on Equity [ROE] in data going back to Q1 2021.
- On a year-over-year basis, Return on Equity [ROE] has declined in each of the last five quarters, with an average year-over-year change of -111.88 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q4 2024, with a gain of 27.51 percentage points; the weakest was Q2 2026, with a drop of 557.76 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -230.59% (Q1 2026), -137.03% (Q4 2025) and -53.41% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | ARS Pharmaceuticals | 357.89 Mn | 219.49 Mn | 27.61 Mn | -71,800.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -71,800.72% |
| Jun 30, 2026 | -583.92% |
| Mar 31, 2026 | -225.72% |
| Dec 31, 2025 | -130.88% |
| Sep 30, 2025 | -47.29% |
| Jun 30, 2025 | -22.75% |
| Mar 31, 2025 | -6.36% |
| Dec 31, 2024 | 3.57% |
| Sep 30, 2024 | -23.36% |
| Jun 30, 2024 | -20.41% |
| Mar 31, 2024 | -21.95% |
| Dec 31, 2023 | -23.38% |
| Sep 30, 2023 | -25.44% |
| Jun 30, 2023 | -21.00% |
| Mar 31, 2023 | -15.85% |
| Dec 31, 2022 | -30.78% |
| Dec 31, 2021 | -12.92% |
| Sep 30, 2021 | -23.22% |
| Jun 30, 2021 | -17.98% |
| Mar 31, 2021 | -26.26% |
API Access
ARS Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SPRY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "SPRY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SPRY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();